Australia's most trusted
source of pharma news
Thursday, 11 September 2025
Posted 11 September 2025 PM
Australian innovation has been recognised at the Asia Pacific Cell & Gene Therapy Excellence Awards 2025, with two companies picking up gongs.
Presented at the 9th Annual Cell & Gene Therapy World Asia 2025 in Singapore last night, Melbourne-based Cartherics won the gong for Most Promising iPSC Therapy Pipeline in APAC, while Sydney-based HaemaLogiX walked away as the winner of Most Promising CAR-T Pipeline in APAC.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.